Chia Tai Enterprises International Limited (CAIHF)

Market Cap	258.76M +335.6%
Revenue (ttm)	469.85M +12.4%
Net Income	30.01M +67.9%
EPS	0.12
Shares Out	n/a
PE Ratio	8.62
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	510
Open	0.2775
Previous Close	0.0100
Day's Range	0.2775 - 0.2800
52-Week Range	0.0100 - 0.2800
Beta	3.99
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About CAIHF

Chia Tai Enterprises International Limited manufactures and sells animal health products and chlortetracycline in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments: Biotech Business and Investment Business. The Biochemical segment is engaged in the manufacture and/or sale of animal health products and chlortetracycline, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance efficiency under the Shihao and Citifac brand names. The I...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 900
• Stock Exchange: OTCMKTS
• Ticker Symbol: CAIHF

Financial Performance

In 2025, CAIHF's revenue was $535.91 million, an increase of 74.14% compared to the previous year's $307.75 million. Earnings were $32.06 million, an increase of 187.03%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 26, 2026

Data Sources Report a data error